Pancreatic ductal adenocarcinoma (PDAC) is frequently detected in late stages, which leads
to limited therapeutic options and a dismal overall survival rate. To date, no robust method …

Pancreatic surveillance can detect early-stage pancreatic cancer and achieve long-term
survival, but currently involves annual endoscopic ultrasound and MRI/MRCP, and is …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy
characterised by late diagnosis and poor prognosis, with current diagnostic and prognostic …

Pancreatic cancer is often detected at a late stage and usually leads to significant morbidity
and deaths 1. The 5-year survival rate for those with pancreatic cancer detected at a …

Background and aims Pancreatic ductal adenocarcinoma (PDAC) is infrequent. Currently,
non-invasive biomarkers for early detection of PDAC are not accessible. Here, we intended …

Background The grim (< 10% 5-year) survival rates for pancreatic ductal adenocarcinoma
(PDAC) are attributed to its complex intrinsic biology and most often late-stage detection …

Objectives: Pancreatic ductal adenocarcinoma (PDAC) is the most pervasive sort of
pancreatic malignant growth. Due to the lack of early symptoms and effective methods for …

Pancreatic cancer (PanCa) is one of the most aggressive forms of cancer and its incidence
rate is continuously increasing every year. It is expected that by 2030, PanCa will become …

Certain cancer types, namely pancreatic cancer is difficult to detect at an early stage;
sparking the importance of discovering the causal relationship between biomarkers and …

Pancreatic ductal adenocarcinoma (PDAC) ranks among the deadliest forms of cancer,
highlighting the urgent need for non-invasive diagnostic procedures to enhance early …